1. Pink Sheet
  2. >>Pathways & Standards
  3. >>User Fees

PDUFA VII: US FDA Says Money Can’t Solve Meeting Problems

 
• By Derrick Gingery

Mid-cycle meeting for some supplements cannot be accommodated without extending the goal date, the agency tells industry negotiators.

Many clocks in a vending machine to illustrate the importance and fleeting nature of time and the desire to buy more and make a moment last longer - Illustration
The FDA said time, not money, is the issue with adding a mid-cycle meeting for prior approval manufacturing supplements. • Source: Shutterstock

More user fee money cannot buy sponsors additional meetings with the US Food and Drug Administration for some application supplements.

That the message from agency officials during negotiations of the next prescription drug user fee program cycle. The FDA proposed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from User Fees

More from Pathways & Standards